MCKESSON CORP (MCK)
Health Care / Health Care Distributors
S&P 500$743.13
Scores poorly across most models. Proceed with caution.
Weak
Score based on 5 of 5 models — high confidence
Is MCKESSON CORP a Good Investment in 2026?
MCKESSON CORP (MCK) scores 3.9 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates MCKESSON CORP as Strong (7/9). However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 71%). MCKESSON CORP currently trades above its estimated fair value of $730, suggesting limited upside at current prices. MCKESSON CORP ranks #859 out of 1126 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading near estimated fair value.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Strong
7/9
Buffett
Neutral
Business quality & competitive moat
Graham
Neutral
Price vs intrinsic value
Lynch
Attractive
PEG 2.3 · Stalwart
Greenblatt
Caution
Bottom half (rank 71%)
Frequently Asked Questions
Is MCKESSON CORP (MCK) a good investment?
What is MCKESSON CORP's Piotroski F-Score?
Is MCK overvalued or undervalued?
How does MCK compare to other Health Care stocks?
What do investment models say about MCK?
Similar Stocks
Compare MCK with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer